JCI vs KLRS
Johnson Controls International PLC (JCI) versus Kalaris Therapeutics, Inc. (KLRS) — a side-by-side from cached financials, not a winner call.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Kalaris Therapeutics, Inc. (KLRS) is a biotechnology company listed on US.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
KLRS does not have a complete income-statement cache yet.
JCI currently screens at market cap $87.62B and trailing P/E 43.9. KLRS currently screens at market cap $0.
Not investment advice. Open the JCI and KLRS stock pages for the full models.
Not investment advice.